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ABSTRACT
Objectives: One of the theories connecting
enterovirus (EV) infection of human islets with type 1
diabetes (T1D) is the development of a fertile field in
the islets. This implies induction of appropriate
proteins for the viral replication such as the coxsackie–
adenovirus receptor (CAR). The aim of this study was
to investigate to what extent CAR is expressed in
human islets of Langerhans, and what conditions that
would change the expression.
Design: Immunohistochemistry for CAR was performed
on paraffin-embedded pancreatic tissue from patients
with T1D (n=9 recent onset T1D, n=4 long-standing
T1D), islet autoantibody-positive individuals (n=14) and
non-diabetic controls (n=24) individuals. The expression
of CAR was also examined by reverse transcription PCR
on microdissected islets (n=5), exocrine tissue (n=5) and
on explanted islets infected with EV or exposed to
chemokines produced by EV-infected islet cells.
Results: An increased frequency of patients with T1D
and autoantibody-positive individuals expressed CAR in
the pancreas (p<0.039). CAR staining was detected more
frequently in pancreatic islets from patients with T1D
and autoantibody-positive subjects (15/27) compared
with (6/24) non-diabetic controls (p<0.033). Also in
explanted islets cultured in UV-treated culture medium
from coxsackievirus B (CBV)-1-infected islets, the
expression of the CAR gene was increased compared
with controls. Laser microdissection of pancreatic tissue
revealed that CAR expression was 10-fold higher in
endocrine compared with exocrine cells of the pancreas.
CAR was also expressed in explanted islets and the
expression level decreased with time in culture. CBV-1
infection of explanted islets clearly decreased the
expression of CAR (p<0.05). In contrast, infection with
echovirus 6 did not affect the expression of CAR.
Conclusions: CAR is expressed in pancreatic islets of
patients with T1D and the expression level of CAR is
increased in explanted islets exposed to
proinflammatory cytokines/chemokines produced by
infected islets. T1D is associated with increased levels
of certain chemokines/cytokines in the islets and this
might be the mechanism behind the increased
expression of CAR in TID islets.
INTRODUCTION
Type 1 diabetes (T1D) is a lifelong disease
characterized by the loss of or severely
reduced number of insulin-producing β cells
in the islet of Langerhans, presence of islet
autoantibodies and, especially in younger
individuals, insulitis consisting of inﬁltration
of the islets predominantly by CD8+ T cells
and macrophages. The etiology of the disease
is unclear but it has been shown that genetic
factors, especially genes in the human leuco-
cyte antigen (HLA) complex, are of major
importance for the pathogenesis. In addition,
several studies have shown that environmen-
tal factors likely contribute to disease devel-
opment.1 2 Enteroviruses (EVs), particularly
the coxsackievirus B (CBV), are among the
main environmental candidates and numer-
ous studies have shown association between
these gut viruses and T1D by different tech-
niques.3–10 In addition, experiments using
isolated human islets have shown that CBVs
are able to infect and replicate in insulin-
producing β cells.4 11–13
CBV belong to the human enterovirus
species B (HEV-B) species. Their genome is
Significance of this study
What is already known about this subject?
▪ It is known that enterovirus, especially
Coxsackievirus B, often can be detected in
human islets of Langerhans in type 1 diabetes
cases.
What are the new findings?
▪ It is not known if and to what extent islet cells
express appropriate virus receptors and if the
expression differs between type 1 diabetes
cases, pre-diabetic cases and non-diabetes
individuals.
How might these results change the focus of
research or clinical practice?
▪ Our finding that the Coxsackie-Adenvirus-
Receptor (CAR) is more frequently expressed in
pancreas from pre-diabetic and in type 1 dia-
betes cases compared to control individuals
suggest the presence of a fertile field in pancreas
in the two former groups.
BMJ Open Diabetes Research and Care 2016;4:e000219. doi:10.1136/bmjdrc-2016-000219 1
Open Access Research
group.bmj.com on May 18, 2017 - Published by http://drc.bmj.com/Downloaded from 
∼7500 nucleotides long and protected by a capsid com-
posed of 180 subunits of the capsid proteins VP1–VP4.
The virions use various receptor molecules to enter
the cell. The main receptor for CBVs is the tight junc-
tion protein Coxsackie–adenovirus receptor (CAR),
which belongs to the large family of adhesion molecules;
however, other receptors have also been shown to be
important for virus internalization.14 15 The full-length
CAR protein comprises two extracellular
immunoglobulin-like domains (D1 and D2), one trans-
membrane helix and an intracellular C-terminal
domain.16 17 At least ﬁve isoforms of CAR are known,
two transmembrane isoforms, which differ only at their
C-terminal, and three lacking the transmembrane
domain that were shown to be secreted in transfected
HeLa cells.18–20 CBV binds the distal end of the D1
domain in the canyon of the virus capsid,21 whereas the
intracellular C domain has been shown to be dispensable
for infection.22 The tissue distribution of CAR in human
tissues has been mainly studied at the transcriptional
level; CAR is expressed in a variety of human organs,
including the pancreas.19 23 The protein is highly
expressed in the brain and heart during murine embry-
onic development, but expression declines rapidly after
birth.24 25 Expression of the CAR protein in human
adult pancreas has been demonstrated in ductal epithe-
lial cells,26 islet cells,27 and exocrine acinar cells (http://
www.proteinatlas.org) by immunohistochemistry (IHC).
Which of the isoforms of the CAR protein is present in
pancreas, and the biological functions of these are not
known. A monoclonal antibody directed against the
extracellular CAR domain28 blocked replication of CBV-4
and CBV-5 in explanted islets, an indirect proof of expres-
sion and function in human islets.4 Furthermore, the
expression of the CAR protein has been noted to be
increased during healing and inﬂammation29 30 and
downregulated in various human cancers.31
The main aim of this study was to investigate the
expression of the CAR gene and protein in pancreatic
tissue, obtained from different groups of patients with
T1D, and to compare it with non-diabetic control indivi-
duals. We also wanted to study how EV infection or
virus-induced inﬂammatory mediators regulate the
expression of CAR in human islets.
MATERIALS AND METHODS
Tissue specimen
Pancreatic parafﬁn-embedded tissue from the pancreatic
head or tail were obtained from non-diabetic donors
with islet cell autoantibodies (n=14), donors with recent
onset T1D (n=9, both from organ donors and from the
DiViD study), donors with long-standing T1D (n=5), and
from control, autoantibody-negative, non-diabetic organ
donors (n=24). Tissues from organ donors were pro-
vided by the Network for Pancreatic Organ Donors with
Diabetes (nPOD) and the Uppsala biobank. Pancreas
biopsies were obtained from the DiViD biobank, Oslo,
Norway (see online supplementary table S1).
Human islet and cell cultures
Pancreatic islets were isolated from the pancreas of
organ donors according to the protocol by Goto et al.32
Islets were then handpicked under a light microscope to
further increase purity to >90%. Islets were cultured free
ﬂoating in six-well plates for suspension cultures
(Sarstedt, Nümbrecht, Germany) in 3 mL RPMI-1640
5.5 mM glucose (SVA, Uppsala Sweden) supplemented
with 10% fetal bovine serum (FBS) (Gibco, Invitrogen,
Stockholm, Sweden). Green Monkey Kidney (GMK)
cells were cultured in 96-well plates (Corning, New York,
USA) in Eagle’s minimum essential medium (EMEM)
(SVA, Uppsala Sweden) supplemented with 10% FBS
(Gibco, Invitrogen, Stockholm, Sweden). All cells were
cultured at 37°C in 5% CO2.
Prolonged culture of islets
Human islets, isolated and further puriﬁed by handpick-
ing, were cultured as described above with change of
culture medium every third day. Total RNA was extracted
on days 1, 4, 8 and 13 (number of donors=2) postisola-
tion to analyze the genes coding for CAR and insulin.
Ethics
The work performed on human tissue was in accordance
with the principles expressed in the Declaration of
Helsinki and the European Council’s Convention on
Human Rights and Biomedicine. Isolation of human
islets of Langerhans and the research performed on
these was approved by the Regional Ethics Committee in
Uppsala, Sweden. Collection of pancreatic tissue in the
DiViD study was approved by the Norwegian Government
Regional Ethics Committee in Oslo, Norway.
Virus
Three strains of CBV-1 were used in the gene expression
study: CBV-1-7-10796 and CBV-1-11-10802 were isolated
in Argentina during 1983 and 1998, respectively,
whereas CBV-1-3-10790 was isolated in the USA in 1973.
All strains were obtained from the Center for Disease
Control and Prevention (CDC), Atlanta, Georgia, USA.
In addition, a strain of echovirus 6 (Echo-6-2C) was
included in this study. This strain was isolated in Cuba
2011 from a patient with meningitis as a part of the
Public Health Surveillance strategies in Cuba on circulat-
ing EV in meningitis cases. The CBV-1 strains were
chosen since CBV-1 has been shown to use CAR as its
main receptor. The Echo-6-2C strain was chosen since
this serotype does not use CAR as a receptor and has
been shown to bind to CD55/decay accelerating factor.33
Immunohistochemistry
Parafﬁn-embedded formalin-ﬁxed pancreatic tissue as
well as parafﬁn-embedded formalin-ﬁxed explanted
islets of Langerhans were sectioned (5 µm) and dried on
Superfrost glass slides (Menzel-Gläzer, Fischer scientiﬁc,
Braunschweig, Germany), followed by de-parafﬁnization
and rehydration in 99.70% ethanol. Antigen retrieval
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was performed in TE-buffer, pH 9 (DAKO, Glostrup,
Denmark) in a steam boiler and permeabilized in TBS
containing 0.05% TWEEN 20. Endogenous peroxidase
was blocked by the use of a ready-to use peroxidase
blocker (DAKO, Glostrup, Denmark). After rinsing,
the sections were incubated with primary antibodies,
mouse anti-CAR (RmcB clone, Millipore, Billerica,
Massachusetts, USA) diluted 1:1000. Incubation with
these antibodies was performed at room temperature for
1 hour and the visualization was achieved with the anti-
mouse Envision-kit (Dako, Glostrup, Denmark) using
3,3’-diaminobenzidine (DAB) as substrate chromogen.
For double staining with CAR and chromogranin A
(mouse, ready to use, Dako, Glostrup), the sections were
visualized using a Polink DS MM D kit polymer-HRP&AP
double staining kit (Golden Bridge, Mukilteo,
Washington, USA).
Virus infection
Handpicked human islets of Langerhans were inocula-
ted with any of the virus strains to obtain a ﬁnal concen-
tration of 103 tissue culture infectious dose (TCID)50.
Aliquots of the culture medium were collected on the
day of infection and every day until day 3 postinfection
(p.i.) for virus replication measurement by TCID50 titra-
tions, and stored at −20°C. On day 3 p.i., all islets and
all cells detached from the islets during culture were
spun down and washed before total RNA was extracted.
Islets inoculated with the CBV-1-11 strain were also har-
vested for western blot (WB) analysis on day 3 p.i. For
IHC analysis, islets from the same donor were inoculated
with CBV-1-11 at a ﬁnal concentration of 102.5–3 TCID50
or mock-infected. On day 4 p.i., they were ﬁxed and
embedded.
Analysis of virus replication
Virus replication was determined by TCID50 titrations of
samples of culture medium on an in house cell line ori-
ginating from GMK cells, obtained from Gothenburg
University, Sweden, as described previously.34 The
samples were collected from the infected islet cultures
on the indicated days p.i.
Treatment with virus-induced proinflammatory chemokines
The effect of inﬂammatory mediators on the expression
level of the CAR gene was analyzed by treating
explanted islets with UV-treated culture medium from
CBV-1-infected human islets (two donors) and by
adding CXCL10 (Peprotech, Stockholm, Sweden) at
ﬁnal concentrations of 0.1, 10 and 50 ng/mL (four
donors) for 1 and 4 days. Total RNA was extracted and
the expression of the gene encoding CAR was analyzed
by quantitative reverse transcription PCR.
RNA extraction and cDNA synthesis
Three days p.i., isolated human pancreatic islets were
washed in phosphate-buffered saline (PBS) and lysed by
using RLT buffer (Qiagen, Sollentuna, Sweden) on
QIAshredder spin columns (Qiagen, Sollentuna,
Sweden). Total RNA was extracted from the infected
and control islets by using the RNAeasy mini kit
(Qiagen, Sollentuna, Sweden) with G DNA eliminator
column to remove the genomic DNA. RNA concentra-
tion and quality were determined with Nanodrop
(Thermo Scientiﬁc, Braunschweig, Germany). Up to
50 ng of total RNA per sample was reverse transcribed to
cDNA in a reaction mixture of 0.5 µL random primer
(300 ng/μL, Invitrogen, Stockholm, Sweden), 1 µL
RNaseOUT (40 U/µL), 4 µL 5× ﬁrst strand buffer, and
1 µL 0.1 M dithiothreitol (DTT) according to the manu-
facturer’s instructions. Reaction was carried out at 25°C
for 10 min, 42°C for 55 min, and 15 min at 75°C.
Real-time PCR
The mRNA expression level of genes encoding CAR,
insulin, and amylase was analyzed with real-time PCR.
The reaction mixture consisting of 10 µL Syber Green
master mix (Applied Biosystems, Stockholm, Sweden),
2 µL primer, and 1 µL cDNA was prepared according
to the manufacturer’s instructions. The reaction was
carried out in a 96-well optical plate on a Step one
plus Real-time PCR system (Applied Biosystems,
Stockholm, Sweden). The cycling conditions were 40
cycles of 15 s at 94°C, 30 s at 55°C and 30 s at 68°C.
Predesigned primers (Quntitect, Qiagen, Sollentuna
Sweden) were used for detection of CAR and 18s. Also,
for amylase and insulin, commercially available primers
were used for analyses of the LMC samples. Real-time
PCR data were analyzed by the comparative delta ct
method. The expression level of the gene encoding CAR
was normalized to the expression of the 18s housekeep-
ing gene by subtracting the 18s ct value from CAR gene ct
values. The relative gene expression levels were calculated
by using the 2^-dct formula and presented as the clustered
columns in MS Excel. Melt curve analysis was used to
verify the speciﬁcity of ﬁnal PCR products.
Western blot
Expression of the CAR protein was analyzed in
explanted human islets infected with CBV-1-11 and
mock infected by WB using a polyclonal antibody
(α-CAR20) as previously described,35 using an antibody
against calnexin (BioNordika Sweden AB, Stockholm) as
loading control.
Statistical analyses
Linear regression and ORs with 95% CIs were used to
test the likelihood of CAR positivity in grouped T1D
donors and non-diabetic controls. Owing to low sample
sizes, the likelihood of CAR positivity in the separate
T1D groups was only measured between autoantibody-
positive donors and non-diabetic controls. Differences in
gene expression levels between control and
virus-infected samples, between different donors and
between the CBV-1 strains were analyzed with the
Kruskal-Wallis test (corresponding to the parametric
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one-way analysis of variance), when comparing data
from more than two independent groups, and the
Mann-Whitney test (corresponding to the parametric
independent samples t-test), when comparing data from
two independent groups. Correlation analyses between
the expression of amylase and exocrine tissue, insulin
and endocrine tissue, and CAR and endocrine/exocrine
tissue were performed with Spearman’s r. The p<0.05
was considered statistically signiﬁcant. All bars are pre-
sented as mean+SEM.
RESULTS
Immunohistochemistry
CAR positivity was signiﬁcantly higher in the combined
T1D and islet autoantibody-positive group (15/27 com-
pared with controls (6/24) in linear regression
(p<0.033), with an OR of 3.877 and between islet
autoantibody-positive subjects and non-diabetic controls
(p<0.039)). The exact ﬁgure of this higher frequency of
CAR-positive staining in the endocrine islets of recent
onset T1D was 5/9, islet autoantibody-positive 8/14, and
long-standing subjects with T1D 2/4 compared with con-
trols 6/24. To be considered positive, the section stained
positive for CAR in a few up to several islets. In
CAR-negative sections from either group of donors, no
staining of CAR was seen. The positive CAR staining
revealed a membranous pattern in the endocrine tissue
(ﬁgure 1A), suggesting the presence of the transmem-
braneous part of CAR.
A somewhat less intense cytoplasmic/membranous CAR
staining was also observed in cells in the exocrine part of
the pancreas in all donors, with CAR-positive endocrine
cells. In addition, in ﬁve donors with T1D, positive staining
for CAR in ductal epithelial cells was seen. In the majority
(30/51) of the pancreatic sections (mainly controls), no
staining for the extracellular domain of CAR was seen in
the endocrine or exocrine tissue.
Virus replication
All EV strains/serotypes used for infection replicated in
the islets. The mean virus titer increase in the culture
medium during 3 days p.i. was 101.8+0.28 (CBV-1-11, n=6),
102.5+0.4 (CBV-1-3, n=7), 102.5+0.40 (CBV-1-7, n=6) and
104.5+0.19 (echovirus 6-2C, n=5) TCID50/200 µL, respect-
ively (ﬁgure 2).
Expression of CAR mRNA
In uninfected control islets (n=3), cultured for an
extended period postisolation, the expression level
of CAR decreased linearly with the time of culture
(ﬁgure 3). Islets infected in vitro with three strains of
CBV-1 revealed a signiﬁcant (p<0.001) reduction in
CAR coding mRNA compared with uninfected control
islets from the same donors (n=6). There were no differ-
ences between the CBV-1 strains in that respect.
However, in islets infected with echovirus-6-2C, which does
not use CAR as a receptor, no reduction of the expression
of CAR mRNA was seen compared with control (ﬁgure
4), indicating that the effect was not due to virus-induced
β-cell death. Comparing the expression level of CAR
between the different CBV-1 strains and the Echo-6-2C
revealed that the difference was similar to that of the dif-
ference between the control and the CBV-1-infected islets.
Figure 2 Mean virus titer increase in human islets, from
control donors, infected in vitro with CBV-1-3 (n=7), CBV-1-7
(n=6), CBV-1-11 (n=6) and Echo-6-2C (n=5). CBV,
coxsackievirus B.
Figure 1 (A) Positive CAR staining in one donor with
GAD65 and IA-2 autoantibodies. (B) CAR staining in isolated
human islets, from control organ donor, infected with a CBV-1
strain. CAR, coxsackie–adenovirus receptor; CBV,
coxsackievirus B.
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CBV-1-11 and CBV-1-3 differed somewhat more compared
with Echo-6-2C (p<0.009) than CBV-1-7 (p<0.004). In
explanted islets cultured in UV-treated culture medium
from infected islets from organ donors, a clear increase of
CAR mRNA was seen after 4 days of culture compared
with islets cultured in UV-treated islet culture medium
from controls (ﬁgure 5).
Western blot
The reduction of the CAR gene seen in islets infected
with strains of CBV-1 was also conﬁrmed on the protein
level. There was a decreased expression of the CAR
protein relative to the housekeeping protein in islets
infected with CBV-1-11 compared with that in mock-
infected islets from the same donor (ﬁgure 6).
DISCUSSION
In this study, we found that frequency of CAR expression
was increased in the pancreatic endocrine tissue from
autoantibody-positive non-diabetic donors and subjects
with T1D compared with controls. This indicates that
CAR may promote virus infection and uptake in endo-
crine cells of pancreatic islets, previously shown to be
permissive to virus infection both in vivo4 and in vitro.12
The reason for the higher percentage CAR positivity in
patients with T1D and prediabetes is not known, but
studies have shown that CAR expression can be induced
by inﬂammation and tissue damage.29 CAR has been
shown to be an inducible protein and increased expres-
sion of CAR has been reported in myocytes in dilated
cardiomyopathy30 and in hearts from subjects with myo-
cardial infarction.24 Increased CAR expression has also
been associated with an ongoing inﬂammation29 and
during formation of cell-to-cell contact due to tissue
destruction.24 25 In fact, we found that UV-treated
culture supernatants of CBV-infected islets induced
similar CAR expression on culture islets, suggesting that
Figure 4 Mean CAR mRNA expression levels in isolated
human islets from control donors infected in vitro with different
EV strains. CAR expression levels were decreased in all islets
infected with strains of CBV-1 compared with the
mock-infected control (p<0.05). In islets infected with the
non-CAR using E6-2C strain, no affect on the CAR expression
level was seen. Bars represent mean±SEM. CAR, coxsackie–
adenovirus receptor; CBV, coxsackievirus B; E6-2C,
Echo-6-2C; EV, enterovirus.
Figure 3 mRNA expression levels of the gene encoding
CAR in isolated human islets from control donors, cultured for
prolonged time (n=2). Islets were cultured for 1, 4, 8 and
12 days and CAR mRNA expression levels were quantified
with qPCR. CAR, coxsackie–adenovirus receptor; qPCR,
quantitative PCR.
Figure 5 mRNA expression levels of the gene encoding
CAR in explanted human islets from control donors, cultured
in UV-treated culture medium derived from CBV-infected
human islets and from mock infected islets. CAR mRNA
expression levels were quantified with qPCR on day 4 of
culture. CAR, coxsackie–adenovirus receptor; CBV,
coxsackievirus B; qPCR, quantitative PCR; UV, ultraviolet.
Figure 6 Western blot analysis of explanted human islets
from control donors infected in vitro with CBV-1-11 revealed
decreased expression of the CAR protein compared with
mock-infected islets from the same donor (n=1). CAR,
coxsackie–adenovirus receptor; CBV, coxsackievirus B.
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CBV infection in islets of Langerhans could be one pos-
sible cause of CAR expression in islets. This supernatant
did not contain infectious virus particles, suggesting that
the effect was due to some inﬂammatory mediators
induced by the virus in infected islets. Previous studies
have shown that CBV infection of human islets induces
several cytokines and chemokines.36 37 We tested the
effect of one of the most abundantly produced chemo-
kines, CXCL10, on islets, but it failed to induce CAR.
Thus, further studies are needed to identify
virus-induced substances that mediate induction of CAR
on human islets. In addition to viral factors, other
factors, such as the autoimmune process itself, may be
involved.
Regardless of the cause of the induction of the splice
variant of CAR that is used by CBV for infection, induc-
tion of this protein may make islet more susceptible for
CBV infection and also promote the spread of ongoing
infection to other islets.17
The expression of CAR in islets from donors with islet
autoantibodies or T1D suggests that islets in these indivi-
duals are potentially more susceptible to CBV infection.
In humans, in contrast to in mice, it seems that islet of
Langerhans are the target tissue for CBV. In contrast to
our ﬁndings in humans, in situ hybridization in pancre-
atic tissue from mice has failed to show any expression
of CAR mRNA in the islets38 that might explain why
mouse islets are normally spared during CBV
infection.38 39
Most studies have failed to detect EV in human exo-
crine tissue, that is, in neonates with systemic EV infec-
tions.4 In vitro studies, in which primary human
exocrine cells were inoculated with two strains of CBV-5,
failed to show any replication and no virus particles
could be detected by electron microscopy in the cells.12
Staining for the extracellular domain of CAR on pan-
creatic tissue sections revealed that most non-diabetic
donors did not express the extracellular domain of CAR.
In contrast, CAR (protein and gene) was expressed in
explanted islets from all donors tested. Prolonged
culture of isolated islets revealed that the expression of
the CAR gene decreased with time of culture, suggesting
that the digestive process of the pancreas during islet
isolation might cause an induction of CAR.
In vitro infection of islets with EVs revealed that in
islets infected with CAR using viruses, the expression of
CAR was decreased, in contrast infection with a
non-CAR using EV, the expression level of CAR was not
affected. One possible explanation for the reduced
expression could be a species-speciﬁc downregulation of
virus receptors, which might lead to inhibition of infec-
tion by a second virus, the so-called superinfection
exclusion.40 This phenomenon has also been described
for several other viruses41 and might favor a slow-
growing, persistent strain. Whether the downregulation
is due to stimulation of certain cytokines, which in
vitro have been shown to decrease the expression level
of the CAR gene42 and also the CAR protein by
promotion of turnover of CAR protein through ubiqui-
tin–proteasome and nuclear factor kappa-light-chain-
enhancer of activated B cells (NFkB)-dependent path-
ways43 or some other factors, remains to be elucidated.
A more likely explanation might be that CAR is down-
regulated by hsa-miR-466d; this has recently been
shown in a rodent b-cell model challenged with
CBV-4.44
In contrast to the decreased expression of CAR during
an acute CBV infection in islet endocrine cells, the
expression of CAR in individuals with acute EV infection
in myocytes was increased.30 Also in EV-positive cases
with dilated cardiomyopathy, a disease with a chronic EV
infection, the expression of the CAR protein was
increased compared with controls.45 Systemic EV infec-
tion has during some epidemics resulted in seroconver-
sion of islet-related autoantibodies, indicating that viral
replication has taken place in the islet cells, with release
of intracellular proteins as a result.46 If such an infection,
in a subgroup of infected individuals, progressed to a
chronic phase with a low-grade viral replication and
ongoing tissue damage, CAR might be induced by EV
infection. This has been shown regarding myocarditis and
its progression in some individuals to dilated myopathy.47
In summary, this study shows that the CAR protein is
expressed in islets of Langerhans in a higher percentage
of individuals with T1D or at risk of T1D compared with
non-diabetic individuals. Increased expression of CAR is
also seen after treatment with proinﬂammatory cyto-
kines/chemokines, and induction of this protein in pan-
creatic islets in vivo might induce a fertiled ﬁeld and this
may also promote the spread of CBV to other islet and
play a role in virus-induced T1D.
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